MAFLD: What Is It?

Houston Methodist

D. Victor

The COVID-19 Global Rheumatology Alliance: Collecting Evidence-Based…

Covid-19 Global Rheumatology Alliance

P. Robinson, J. Yazdany

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

Liver Fat, Iron, Fibrosis, (and T1): Quantitative MRI in Chronic Liv…

UCSF School of Medicine

M. A. Ohliger

Pharmacologic Management of Alcohol Use Disorder

Scripps Health

R. Lee

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

Current Treatment of Metabolic Dysfunction Associated with Steatotic…

Indiana University School of Medicine Division of Gastroenterology and Hepatology

N. Samala

Updates in Management for Patients with Cirrhosis

Duke Health

R. Doshi

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Caring for the Post Liver Transplant Patient in the Primary Care Set…

University of Colorado Department of Medicine

B. Henderson, M. O'Meara

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan

Evaluating Liver-Related Mortality and Liver Transplant Outcomes

Stanford Medicine

W. Ray Kim

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

Medical Management of Metabolic Associated Steatotic Liver Disease

Michigan Medicine

R. Fontana

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

The Evolving Landscape of Non-Alcoholic Fatty Liver Disease (NAFLD) …

Cardiometabolic Health Congress (CMHC)

K. Cusi

Rising Burden of Alcohol Use Disorder: Management and Outcomes

Scripps Health

J. Gutierrez

Fatty Liver Disease: When to Refer?

Yale School of Medicine

NAFLD: Updates in Management

UChicago Medicine

M. E. Rinella